marginally significantP = 0.054
Microstate C revealed, on a marginally significant level, less coverage ( F (1,84) = 3.810, P = 0.054, ETA 2 = 0.043) under oxytocin treatment ( M = 25.47%, s.d. = 4.01%) compared to placebo treatment ( M = 27.27%, s.d. = 4.56%).